Literature DB >> 33189582

Ivermectin: An Anthelmintic, an Insecticide, and Much More.

Richard J Martin1, Alan P Robertson2, Shivani Choudhary2.   

Abstract

Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and recent studies that have sought to reposition ivermectin for the treatment of other diseases that are not caused by helminth and insect parasites. The standard theory of its anthelmintic and insecticidal mode of action is that it is a selective positive allosteric modulator of glutamate-gated chloride channels found in nematodes and insects. At higher concentrations, ivermectin also acts as an allosteric modulator of ion channels found in host central nervous systems. In addition, in tissue culture, at concentrations higher than anthelmintic concentrations, ivermectin shows antiviral, antimalarial, antimetabolic, and anticancer effects. Caution is required before extrapolating from these preliminary repositioning experiments to clinical use, particularly for Covid-19 treatment, because of the high concentrations of ivermectin used in tissue-culture experiments.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  anthelmintic; anticancer; antimalaria; antivirus; insecticide; ivermectin

Mesh:

Substances:

Year:  2020        PMID: 33189582      PMCID: PMC7853155          DOI: 10.1016/j.pt.2020.10.005

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  102 in total

Review 1.  The pharmacokinetics and metabolism of ivermectin in domestic animal species.

Authors:  Aránzazu González Canga; Ana M Sahagún Prieto; M José Diez Liébana; Nélida Fernández Martínez; Matilde Sierra Vega; Juan J García Vieitez
Journal:  Vet J       Date:  2007-09-11       Impact factor: 2.688

2.  Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

Authors:  R M Krause; B Buisson; S Bertrand; P J Corringer; J L Galzi; J P Changeux; D Bertrand
Journal:  Mol Pharmacol       Date:  1998-02       Impact factor: 4.436

3.  The genetics of ivermectin resistance in Caenorhabditis elegans.

Authors:  J A Dent; M M Smith; D K Vassilatis; L Avery
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 4.  Inhibitors of nuclear transport.

Authors:  David A Jans; Alexander J Martin; Kylie M Wagstaff
Journal:  Curr Opin Cell Biol       Date:  2019-02-28       Impact factor: 8.382

5.  Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system.

Authors:  Harshada Ketkar; Long Yang; Gary P Wormser; Penghua Wang
Journal:  Diagn Microbiol Infect Dis       Date:  2019-03-29       Impact factor: 2.803

6.  Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States.

Authors:  Katrina L Mealey; Steven A Bentjen; Denise K Waiting
Journal:  Am J Vet Res       Date:  2002-04       Impact factor: 1.156

7.  Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans.

Authors:  D F Cully; D K Vassilatis; K K Liu; P S Paress; L H Van der Ploeg; J M Schaeffer; J P Arena
Journal:  Nature       Date:  1994-10-20       Impact factor: 49.962

8.  The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.

Authors:  Alice Melotti; Christophe Mas; Monika Kuciak; Aiala Lorente-Trigos; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO Mol Med       Date:  2014-10       Impact factor: 12.137

9.  Toxocara canis: molecular basis of immune recognition and evasion.

Authors:  Rick M Maizels
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

10.  Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.

Authors:  Dobrin Draganov; Sailesh Gopalakrishna-Pillai; Yun-Ru Chen; Neta Zuckerman; Sara Moeller; Carrie Wang; David Ann; Peter P Lee
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

View more
  14 in total

1.  Nodulisporic acid produces direct activation and positive allosteric modulation of AVR-14B, a glutamate-gated chloride channel from adult Brugia malayi.

Authors:  Shivani Choudhary; Melanie Abongwa; Sudhanva S Kashyap; Saurabh Verma; Gunnar R Mair; Daniel Kulke; Richard J Martin; Alan P Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

2.  Effects of Gasterophilus pecorum infestation on the intestinal microbiota of the rewilded Przewalski's horses in China.

Authors:  Dini Hu; Yuzhu Chao; Boru Zhang; Chen Wang; Yingjie Qi; Make Ente; Dong Zhang; Kai Li; Kai Meng Mok
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

Review 3.  Heartworm disease - Overview, intervention, and industry perspective.

Authors:  Sandra Noack; John Harrington; Douglas S Carithers; Ronald Kaminsky; Paul M Selzer
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2021-04-27       Impact factor: 4.077

Review 4.  High-content approaches to anthelmintic drug screening.

Authors:  Mostafa Zamanian; John D Chan
Journal:  Trends Parasitol       Date:  2021-06-03

5.  Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.

Authors:  Lucy Kerr; Flavio A Cadegiani; Fernando Baldi; Raysildo B Lobo; Washington Luiz O Assagra; Fernando Carlos Proença; Pierre Kory; Jennifer A Hibberd; Juan J Chamie-Quintero
Journal:  Cureus       Date:  2022-01-15

6.  Ivermectin: 21st Century "Snake Oil" or Safe and Effective for COVID-19?

Authors:  Patricia Anne O'Malley
Journal:  Clin Nurse Spec       Date:  2022 Jan-Feb 01       Impact factor: 1.067

Review 7.  The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review.

Authors:  Asiya Kamber Zaidi; Puya Dehgani-Mobaraki
Journal:  J Antibiot (Tokyo)       Date:  2021-12-21       Impact factor: 2.649

8.  Comparative analysis on transcriptomics of ivermectin resistant and susceptible strains of Haemonchus contortus.

Authors:  Waresi Tuersong; Caixian Zhou; Simin Wu; Peixi Qin; Chunqun Wang; Wenda Di; Lu Liu; Hui Liu; Min Hu
Journal:  Parasit Vectors       Date:  2022-05-07       Impact factor: 4.047

Review 9.  ABCB1 in dermatology: roles in skin diseases and their treatment.

Authors:  H J Weng; T F Tsai
Journal:  J Mol Med (Berl)       Date:  2021-08-09       Impact factor: 5.606

10.  Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol.

Authors:  Fernando Salvador; Ana Lucas-Dato; Silvia Roure; Marta Arsuaga; Asunción Pérez-Jacoiste; Magdalena García-Rodríguez; José A Pérez-Molina; Dora Buonfrate; José María Saugar; Israel Molina
Journal:  Pathogens       Date:  2021-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.